SLC5A2 and Insulin resistance: In addition, evidence indicates that not only do SGLT2 inhibitors improve hyperglycemia but they also improve insulin resistance, hyperlipidemia, and obesity (Kurosaki & Ogasawara, 2013; Takase, Nakamura, Miyoshi, Yamamoto, & Atsumi, 2017).